Strategic Consulting to Simplify Your Drug Development
Optimize your trial design and drug development strategies with our industry-leading strategic consulting services. We offer expert guidance to ensure precision and efficiency from conception to commercialization.
Clinical Trial Strategic Consulting Services
At Cytel’s Strategic Consulting Group, science meets strategy to advance your drug development journey. Our multidisciplinary team of experts specializes in advancing trial design science, offering unparalleled guidance in statistical design, trial deployment, real-world solutions, and regulatory strategies.
From nonclinical development to adaptive trial designs, we provide proven expertise and innovative methodologies to optimize the speed, savings, and probability of success of your clinical trials. Combining deep scientific knowledge with cutting-edge technology, we empower you to make informed decisions with confidence, helping you to navigate the complexities of drug development with precision and efficiency.
Our Solutions
Innovative Statistics and Adaptive Trial Design
Discover our meticulously crafted trial designs infused with advanced analytical methods to give you greater precision and ensure regulatory compliance. Our approach enhances efficiency, elevating your probability of success while optimizing resources for a more seamless drug development journey.
Advanced Analytics Consulting
We harness the power of cutting-edge analytical methods to glean actionable insights, driving innovation and efficiency in drug development. Our advanced techniques ensure you stay ahead of industry trends, enabling informed decision-making and helping you to maximize the success of your clinical trials.
Regulatory Strategy
Defining your regulatory strategy early during development increases the chances of doing the right thing at the right time, helping to avoid failures due to constraints in time and funding. Our regulatory experts design strategies that align with regulatory expectations and boost your chances of approval.
Clinical Development Strategy and Planning
We work with you to design a successful clinical strategy with a systematic and forward-looking framework, encompassing key components, including clinical hypothesis, clinical endpoints and measures (PK/PD, biomarker, PRO), trial design, go/no-go milestone decision, patient population, and more.
Clinical Pharmacology Consulting
Clinical pharmacology is a vital part of your drug development journey. We can help you build a solid clinical pharmacology program to ensure optimal doses are chosen for later-phase development and labeling is sufficient for clinicians to prescribe the drug safely.
Nonclinical Development Design
Nonclinical development is a must in every drug development project. Our experts can help you determine a drug candidate's safety and efficacy before entering human trials in all phases of development.
Chemistry, Manufacturing, and Controls (CMC)
Our pharmaceutical development and CMC teams work with you to ensure that your medicinal drug will be delivered to the right place, at the right time, and in the right amount, every time it is administered to a patient.
>30
Years of adaptive, group sequential, and Bayesian publications.
100%
Regulatory acceptance of our data sets and trial designs
20%
Up to 20% reduction in average study duration
30
Top 30 pharma companies use Cytel services and technology
eBook Adaptive Oncology Studies
Read our latest eBook on innovative trial design and key regulatory guidance within oncology.
Download eBook
Related Insights
ELEVATE-GenAI: A New Guideline for Reporting Generative AI in HEOR Workflows
From Regulators to Reimbursement: What the EMA-FDA AI Principles Mean for HEOR
Choosing AI for Clinical Workflows: What the Transparency Index Tells Us About Model Quality
Claim your free 30-minute strategy session
Book a free, no-obligation strategy session with a Cytel expert to get advice on how to improve your drug's probability of success and plot a clearer route to market.